Articles tagged with Parkinsons Disease
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A preliminary study found that golf was better than tai chi in improving balance and mobility for people with Parkinson's disease. Golf participants were also more likely to continue with the activity, which may be attributed to its popularity among older adults.
Researchers at Osaka City University discover sesaminol protects against neuronal damage and increases dopamine levels in Parkinson's disease models. The study suggests sesaminol may be the first-ever medicine for Parkinson's disease, potentially derived from industrial waste.
Grafting neurons from monkeys' own cells into their brains relieved debilitating movement and depression symptoms associated with Parkinson's disease. The autologous transplants showed significant improvements within six months, with dopamine levels doubling and tripled within a year.
A genetic study of Lewy body dementia suggests that the disease is caused by a spectrum of problems seen in both Alzheimer's and Parkinson's diseases. Five genes have been identified as critical to the development of Lewy body dementia, with variations in these genes also linked to increased risk of Alzheimer's and Parkinson's diseases.
Researchers have discovered that alpha-synuclein, a protein present in everyone's brains, sticks to the inner face of nerve cell membranes and can kill healthy brain cells. The study sheds new light on the origins of Parkinson's Disease, a neurodegenerative disorder affecting millions worldwide.
A monitoring system based on smartwatches detects movement issues and tremors in Parkinson's patients, allowing for remote monitoring and adjusted medication plans. The platform showed promising results, with 94% match between clinician evaluations and patient data.
Scientists have identified neurons responsible for rapidly stopping behaviors and actions in patients with Parkinson's disease. These 'stop signal neurons' are critical in canceling planned movements, a skill that is lost in the condition. The discovery has the potential to improve deep brain stimulation treatment outcomes.
Researchers found changes in gut microbiome composition correlate with higher levels of toxic bile acids in people with Parkinson's. The findings suggest bile acids may be a viable biomarker for diagnosing Parkinson's early and tracking its progression.
A large observational study found that taking terazosin for enlarged prostate is associated with a reduced risk of developing Parkinson's disease. Men taking terazosin were 12-37% less likely to develop the disease compared to those taking tamsulosin, according to the study published in JAMA Neurology.
Researchers used an 'organs-on-a-chip' system to model the influence of gut bacteria on brain health and found that short-chain fatty acids can worsen Parkinson's disease. The study suggests a link between lipid metabolism and neurodegenerative diseases, highlighting the complex interactions between the gut and brain.
A new study reveals that genetic variations associated with Parkinson's disease alter the action of ion channels within lysosomes, a cellular organelle responsible for waste removal and recycling. These variations increase or decrease disease risk by influencing the function of an ion channel in cells' recycling centers.
Researchers at TU Wien have developed a new approach to single-atom catalysis, which can lead to more effective and cost-efficient catalysts. The study reveals that customized properties through tailored surfaces can change the reactivity of individual atoms, making expensive metals like platinum less necessary.
A recent study found no association between gut fungi and Parkinson's disease, contrary to previous studies on the bacterial microbiome. The researchers analyzed fecal samples from 95 PD patients and 57 controls, concluding that fungi were sparse in the gut microbiomes of PD patients.
Researchers at Ben-Gurion University of the Negev have discovered a protein BMP5/7 that shows promise in slowing or halting Parkinson's disease progression. Current therapies improve symptoms but do not address advanced stages.
Researchers at Nagoya University found that blood pressure, hematocrit, and serum cholesterol levels change in patients with Parkinson's disease long before the onset of motor symptoms. These biomarkers may help detect early signs of developing Parkinson's disease.
Researchers found that people with Parkinson's disease who have visual problems are more likely to develop dementia, with underlying changes in brain wiring explaining the connection. Vision tests may provide a window of opportunity to predict Parkinson's dementia before it begins.
A study conducted at the University of Turku found that patients with schizophrenia have an increased risk of developing Parkinson's disease. The research suggests that alterations in the brain's dopamine system may be a key factor contributing to this increased risk.
Researchers found a strong correlation between following the MIND and Mediterranean diets and later onset of Parkinson's disease in women up to 17.4 years and men up to 8.4 years. The study suggests nutrition could potentially delay the disease.
Researchers at Uppsala University have discovered a link between faulty L-Dopa metabolism and severe side effects in Parkinson's patients. Abnormally elevated levels of L-Dopa and its metabolite were detected in brain regions outside the striatum, suggesting alternative mechanisms underlying motor disorders.
Researchers found that focused ultrasound improved parkinsonian symptoms by 10 points in treated patients, with potential benefits for those with asymmetrical symptoms and limited treatment options. However, further refinements of the technology are needed to ensure reliability and safety.
Researchers are using cutting-edge MRI sensors to map brain responses to drugs of abuse and identify genes that promote neuron survival. They plan to apply this technology to study Parkinson's disease, hoping to uncover new therapeutic targets.
A study published in JAMA Psychiatry found that patients with Parkinson disease in Taiwan were at a higher risk of suicidal thoughts and behaviors compared to the general population. The research highlights the need for improved mental health support and early intervention strategies for individuals with Parkinson disease.
Researchers have produced genetically modified tomatoes enriched in L-DOPA, a natural source for the essential medicine. The development offers benefits for people who suffer from adverse effects of chemically synthesized L-DOPA.
Researchers have identified electrical oscillations in Parkinson's patients' scalps that are coupled with brain activity, suggesting a key to understanding the disease's characteristic movement slowing. The study's findings could lead to novel therapies and shed light on the connection between cognitive disorders and motor symptoms.
A virtual study using AI technology is evaluating speech disorders related to Parkinson's disease, aiming to improve assessment and treatment options. The study aims to provide insights into standardization, earlier diagnoses, and tracking discrete changes to guide interventions.
Researchers developed an AI-powered method to detect Parkinson's disease from retinal images, identifying smaller blood vessels as key features. The approach is less costly and more accessible than traditional brain imaging techniques.
SpeechVive Inc. offers free remote calibration software and training to improve speech volume and clarity in people with Parkinson's disease, bridging the gap for rural patients during COVID-19.
Researchers have developed a new technique for isolating parvalbumin-expressing neurons, which are linked to Parkinson's disease symptoms. The method uses Cre-specific nuclear anchored independent labeling and has been shown to detect changes in oxygen-sensing genes in diseased neurons.
Researchers used machine learning to analyze mitochondrial interaction networks and identified specific patterns associated with Parkinson's disease. These patterns were correlated with clinical scores and allowed for accurate diagnosis of PD patients.
A new study reveals that patients with Parkinson's disease may have an undetected rare neurodegenerative disorder called NIID. Symptoms of NIID include dementia and poor balance. Researchers found NIID-causing mutations in those diagnosed with PD, suggesting a link between the two conditions.
A new study published in the journal Brain found that patients with Parkinson's disease who experience tremor symptoms do not benefit from dopaminergic medication on their learning abilities. In contrast, patients without tremor show improvement in reward learning and faster deterioration of cognitive abilities.
A new brain imaging technology, BrainPhys, has been developed to support optimal neuronal function and viability in live imaging experiments. This breakthrough could lead to better personalised medicine for brain disorders such as Parkinson's, brain cancer, and childhood dementia.
Research reveals basal ganglia neurons primarily use firing rate changes to control voluntary movements, with synchronized activity having a minor role in healthy conditions. Parkinson's disease symptoms may be improved by targeting abnormally increased correlated activity in the basal ganglia.
A double-blind clinical trial investigates the effectiveness of ondansetron, a cancer anti-sickness drug, in alleviating hallucinations in people with Parkinson's. The study aims to find new treatments for this challenging symptom, which affects 75% of UK Parkinson's patients.
Researchers explore potential link between COVID-19 and Parkinson's disease, citing three case studies with improved symptoms after treatment. The study suggests that severe inflammation, blood clots, and neurotropic effects of SARS-CoV-2 may contribute to Parkinson's onset.
Researchers have developed a simple skin test that can accurately diagnose Parkinson's disease by detecting clumping of the protein alpha-synuclein. The assay was tested on 50 skin samples from patients with Parkinson's disease, achieving high sensitivity and specificity rates, promising an earlier diagnosis and better clinical trials.
Research led by Swansea University discovered that ghrelin blocks brain cell formation and is linked to Parkinson's dementia. The study found the UAG form of ghrelin reduces nerve cell formation and impairs memory.
Research by Sahar El Aidy and her team from the University of Groningen found that gut bacteria can deaminate levodopa, a main treatment for Parkinson's disease, into DHPPA, reducing gut motility. This metabolite may worsen constipation in patients with Parkinson's disease.
A novel study finds key brain cell type changes involving lipids and inflammation in Parkinson's disease. The research suggests that microglia are overloaded with lipids, while astrocytes lose lipid content, leading to neuroinflammation and disease progression.
A Cleveland Clinic researcher has been awarded a grant to identify biomarkers for predicting dementia in patients with Parkinson's disease. The five-year project aims to develop a predictive model using imaging, blood, and genetics data to identify individuals at risk of developing dementia as their disease progresses.
Researchers discovered markers of Alzheimer's, Parkinson's and motor neurone disease in the brains of young Mexico City residents exposed to dirty air, linked to particulate pollution. Tiny nanoparticles were also found, which can cause inflammation and oxidative stress.
A new study has found that people with Parkinson's disease have a 30% higher risk of dying from COVID-19 compared to those without the condition. The analysis, conducted by researchers at the University of Iowa Health Care, also found that patients with PD were generally older and more likely to be male than those without PD.
Researchers found that spinal cord stimulation decreased pain and reduced motor symptoms in Parkinson's disease patients by an average of 59% and 12%, respectively. The therapy also showed promise in improving functional mobility and balance.
Researchers at the University of Wisconsin-Madison have developed a stem cell treatment that repairs Parkinson's-damaged brain circuits in mice. The treatment involves coaxing human embryonic stem cells to differentiate into dopamine-producing neurons, which then integrate into the correct regions of the brain and restore motor functions.
Researchers have identified two variants of Parkinson's disease, with one starting in the intestines and spreading to the brain, and another starting in the brain and affecting the intestines and heart. This discovery could lead to personalized medicine and new treatment options for patients.
A team of researchers developed an innovative approach to identify and evaluate candidate molecules that can image and track the progression of Parkinson's disease. They screened millions of compounds using a high-throughput computational method, identifying two promising candidates with extremely high binding affinity to alpha-synuclein.
The team will investigate the molecular linkages between aging and Parkinson's, exploring whether decreasing senescence can slow or stop the disease. Genetic predisposition and age are critical factors in defining a person's risk for Parkinson's.
The study found that patients in low-income countries faced significant difficulties accessing their Parkinson's disease medication, leading to worsening symptom control and increased disability. Global health inequities worsened by COVID-19, with resource-poor countries disproportionately affected.
The $7.2 million grant will fund research across three UC San Diego laboratories and two others based in Germany to understand the basic mechanisms underlying Parkinson's disease. Researchers aim to unravel the biology of LRRK2, a protein linked to genetically inherited Parkinson's disease.
A new slow-release pill developed by Nanyang Technological University, Singapore, aims to alleviate Parkinson's disease symptoms and improve patient compliance. The pill delivers L-dopa over a 24-hour period, reducing the need for multiple daily doses.
A study found that people with Parkinson's are twice as likely to experience orthostatic hypotension, a sudden drop in blood pressure that can lead to dizziness and falls. Monitoring blood pressure may help control these drops and prevent falls.
Researchers analyzed Parkinson's patient skin cells to discover reduced protein synthesis due to active LRRK2 enzyme. Adding LRRK2 inhibitor drugs restored normal protein production levels. The study suggests a critical role for LRRK2 in controlling protein synthesis and may lead to biomarker development and improved treatment options.
A team led by Michigan State University is developing diamond devices to monitor brain biochemistry for early warning signs of Parkinson's disease. The devices aim to detect low levels of dopamine, a chemical neurons use to communicate, and could potentially treat the disease earlier.
Researchers at University of Luxembourg have identified a genetic form of Parkinson's disease caused by a splicing error, offering new potential pharmacological treatments. The discovery was made using patient-based cell cultures reprogrammed into nerve cells in vitro.
The journal features original research articles on Parkinson's Disease and drug-induced interstitial lung disease, as well as a case report and opinion piece on breast cancer management during the COVID-19 pandemic. Open access publishing and author support are also highlighted.
A study using iPSC technology reveals astrocytes' role in PD pathology, including altered alpha-synuclein production and disrupted calcium homeostasis. The findings suggest LRRK2 and GBA mutant astrocytes contribute to PD progression.
A study reveals that amyloid protein alpha-synuclein found in Parkinson's brains is also present in skin cells producing melanin, modulating protein fibril formation and suggesting a molecular link between the two diseases. The discovery may explain the observed association between Parkinson's disease and melanoma.
Researchers have discovered a series of misfolded alpha-synuclein protein structures that are thought to be highly relevant to the onset of Parkinson's disease. These unique structures were found in the presence of phospholipids, which play an essential role in living cells, and take on a striking variety of shapes.
A new study suggests that following an alternate Mediterranean or Alternative Healthy Eating Index diet pattern may be linked to fewer non-motor symptoms such as constipation, daytime sleepiness and depression. The researchers found a strong relationship between healthy diet adherence and reduced risk of these preceding symptoms.
Scientists at University of California San Diego have produced the first visualizations of LRRK2 inside its natural cellular environment and the first high-resolution blueprint of the protein. They discovered how LRRK2 binds to microtubules, acting as a roadblock for motors that move along these tracks.